The prognostic significance of vascular invasion by endometrial carcinoma
- PMID: 8839550
- DOI: 10.1002/(SICI)1097-0142(19961001)78:7<1447::AID-CNCR11>3.0.CO;2-#
The prognostic significance of vascular invasion by endometrial carcinoma
Abstract
Background: Recently, invasion of vascular spaces by endometrial carcinoma has received particular attention as a prognostic factor. The goal of the current investigation was to re-examine the effect of vascular invasion on tumor recurrence and survival in patients with endometrial carcinoma.
Methods: Surgical specimens from 238 patients with endometrial carcinoma were examined for the presence of vascular invasion by tumor cells. Vascular invasion was compared with clinicopathologic features and postoperative survival. Survival curves by vascular invasion were evaluated by the Kaplan-Meier method.
Results: In a histopathologic review of 238 cases of endometrial carcinoma, 82 neoplasms demonstrated vascular invasion. Vascular invasion significantly correlated with the extension of primary tumor, depth of myometrial invasion, and histologic grade. Patients with lymph node metastasis had a significantly higher incidence of vascular invasion. Survival at 5 years for patients with vascular invasion was 73.4%. This was significantly lower than the survival rate of 91.5% for women without this finding (P < 0.001). Among patients with lymph node metastasis, 80.2% of the patients with vascular invasion survived for 5 years compared with 95.3% of the patients without vascular invasion (P < 0.05). Ten of 47 patients with no lymph node metastasis but with vascular invasion developed recurrent carcinoma. Nine of these ten patients apparently had extrapelvic recurrences.
Conclusions: The presence of vascular invasion is a reliable prognostic indicator. Recording of tumor recurrence pattern may lead to a better selection of patients for adjuvant systemic therapy after surgery.
Similar articles
-
[Multivariate analysis of prognostic factors in endometrial carcinoma].Ai Zheng. 2004 Sep;23(9):1085-8. Ai Zheng. 2004. PMID: 15363208 Chinese.
-
Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.Gynecol Oncol. 2005 Mar;96(3):651-7. doi: 10.1016/j.ygyno.2004.11.026. Gynecol Oncol. 2005. PMID: 15721407
-
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.Gynecol Oncol. 2000 Apr;77(1):55-65. doi: 10.1006/gyno.2000.5737. Gynecol Oncol. 2000. PMID: 10739691
-
Peritumorous lymph-vascular invasion, grade of histologic differentiation, and myometrial infiltration as prognostic factors of endometrial carcinoma.Rev Paul Med. 1993 May-Jun;111(3):385-90. Rev Paul Med. 1993. PMID: 8108630 Review.
-
[Adjuvant chemotherapy for high-risk endometrial carcinoma].Nihon Rinsho. 2004 Oct;62 Suppl 10:356-9. Nihon Rinsho. 2004. PMID: 15535267 Review. Japanese. No abstract available.
Cited by
-
Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy.Radiat Oncol J. 2022 Jun;40(2):103-110. doi: 10.3857/roj.2021.00864. Epub 2022 May 25. Radiat Oncol J. 2022. PMID: 35796113 Free PMC article.
-
The prognostic significance of tumor lymphangiogenesis and lymphatic vessel density in endometrioid carcinoma of the uterine corpus.Oncol Lett. 2017 Nov;14(5):5313-5318. doi: 10.3892/ol.2017.6885. Epub 2017 Sep 4. Oncol Lett. 2017. PMID: 29113165 Free PMC article.
-
Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.Gynecol Oncol. 2016 Mar;140(3):387-93. doi: 10.1016/j.ygyno.2016.01.002. Epub 2016 Jan 6. Gynecol Oncol. 2016. PMID: 26768835 Free PMC article.
-
Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion.J Gynecol Oncol. 2015 Jul;26(3):208-13. doi: 10.3802/jgo.2015.26.3.208. Epub 2015 Jan 26. J Gynecol Oncol. 2015. PMID: 25686395 Free PMC article.
-
Treatment of pure uterine sarcoma at the Institut Català D'Oncologia.Rep Pract Oncol Radiother. 2013 Jan 16;18(3):153-8. doi: 10.1016/j.rpor.2012.12.004. eCollection 2013. Rep Pract Oncol Radiother. 2013. PMID: 24416547 Free PMC article.